Most microdosers describe weight loss that occurs more slowly than with standard doses, but feels more manageable
Roswell Organization for Community DevelopmentThe organizations telemedicine program improves healthcare access for Black and Hispanic populations in North Fulton and Cherokee Counties
Mattioli : Weve observed that patients who discontinue GLP-1 therapy often feel much better when continuing probiotic supplementation
The DPV initiative is funded by the German Center for Diabetes Research (DZD, grant no
Improving Adherence and Accessibility of GLP-1 Therapies in Adolescents Despite their benefits, adherence challenges remain a major concern, particularly among adolescents who may struggle with long-term commitment to injectable medications
GLP-1 Revenue Growth Trend 190 Obesity Drugs in the Pipeline According to IQVIAs 2026 analysis, the obesity drug pipeline now contains 190 products in development including next-generation GLP-1 combinations, oral formulations, and triple-receptor agonists
